510(k) K223435

FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System by Abbott Diabetes Care, Inc. — Product Code QBJ

K223435 is an FDA 510(k) premarket notification submitted by Abbott Diabetes Care, Inc. for the device "FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Apr 13, 2023. The device falls under product code QBJ (Integrated Continuous Glucose Monitoring System, Factory Calibrated), a Class II device regulated under 21 CFR 862.1355. Abbott Diabetes Care, Inc. has 39 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 13, 2023
Date Received
Nov 14, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Integrated Continuous Glucose Monitoring System, Factory Calibrated
Device Class
Class II
Regulation Number
862.1355
Review Panel
CH
Submission Type
510(k)

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

Need the full FDA record for Abbott Diabetes Care, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K223435. Report a data issue: hello@regdatalab.com.